386 related articles for article (PubMed ID: 21453285)
1. Adeno-Associated Virus (AAV) Vectors in the CNS.
McCown TJ
Curr Gene Ther; 2011 Jun; 11(3):181-8. PubMed ID: 21453285
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus (AAV) vectors in the CNS.
McCown TJ
Curr Gene Ther; 2005 Jun; 5(3):333-8. PubMed ID: 15975010
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vectors and neurological gene therapy.
Ojala DS; Amara DP; Schaffer DV
Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
[TBL] [Abstract][Full Text] [Related]
4. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
[TBL] [Abstract][Full Text] [Related]
5. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
[TBL] [Abstract][Full Text] [Related]
6. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
Grimm D; Kay MA
Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
[TBL] [Abstract][Full Text] [Related]
7. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
Saraiva J; Nobre RJ; Pereira de Almeida L
J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
[TBL] [Abstract][Full Text] [Related]
9. The state of the art of adeno-associated virus-based vectors in gene therapy.
Coura Rdos S; Nardi NB
Virol J; 2007 Oct; 4():99. PubMed ID: 17939872
[TBL] [Abstract][Full Text] [Related]
10. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
11. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy and neurodevelopmental disorders.
Gray SJ
Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
[TBL] [Abstract][Full Text] [Related]
13. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
Liu Y; Siriwon N; Rohrs JA; Wang P
Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
[TBL] [Abstract][Full Text] [Related]
14. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
15. Adeno-Associated Virus Vector for Central Nervous System Gene Therapy.
Zhu D; Schieferecke AJ; Lopez PA; Schaffer DV
Trends Mol Med; 2021 Jun; 27(6):524-537. PubMed ID: 33895085
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
17. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
[TBL] [Abstract][Full Text] [Related]
18. Human Hepatocyte Transduction with Adeno-Associated Virus Vector.
Song Z; Shao W; Song L; Pei X; Li C
Methods Mol Biol; 2022; 2544():83-93. PubMed ID: 36125711
[TBL] [Abstract][Full Text] [Related]
19. Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.
Castle MJ; Turunen HT; Vandenberghe LH; Wolfe JH
Methods Mol Biol; 2016; 1382():133-49. PubMed ID: 26611584
[TBL] [Abstract][Full Text] [Related]
20. Widespread Central Nervous System Gene Transfer and Silencing After Systemic Delivery of Novel AAV-AS Vector.
Choudhury SR; Harris AF; Cabral DJ; Keeler AM; Sapp E; Ferreira JS; Gray-Edwards HL; Johnson JA; Johnson AK; Su Q; Stoica L; DiFiglia M; Aronin N; Martin DR; Gao G; Sena-Esteves M
Mol Ther; 2016 Apr; 24(4):726-35. PubMed ID: 26708003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
